Anonymous ID: 4872eb March 21, 2020, 8:33 a.m. No.8502033   🗄️.is 🔗kun   >>2115 >>2152 >>2404 >>2625

MAGMA89 on final and 88(formerly) on approach to Barranquilla, Columbia-Ernesto Cortissoz airport.

Both of these out of San Juan, PR and have been in Honduras recently as well as the trips from/to Homestead ARB and Eglin AFB

Anonymous ID: 4872eb March 21, 2020, 8:59 a.m. No.8502264   🗄️.is 🔗kun   >>2287

>>8502226

slept in too. an extra hour can make all the difference. good to hear g doing ok-say hello for us.

doggo already giving the stank eye as it's sunny-they know. follows me around after about 830am and does not stop until we go.

Anonymous ID: 4872eb March 21, 2020, 9:25 a.m. No.8502517   🗄️.is 🔗kun   >>2528

Johnson & Johnson tests 10 variants of coronavirus vaccine

 

Dutch unit draws on experience with Ebola and HIV treatments.

 

Johnson & Johnson is leveraging its technologies used in the development of vaccines for Ebola, Zika, and HIV in a race to stop the spread of COVID-19, the illness caused by the new coronavirus. The deadly outbreak has galvanized researchers across the globe, and countries and companies are rushing find treatments and develop a vaccine as the death toll rises. On Tuesday, the Chinese government said an influenza medicine, Avigan, developed by a group company of Japan's Fujifilm Holdings, is effective against the coronavirus.

 

Indonesian President Joko "Jokowi" Widodo said Friday that the country is importing millions of doses of Avigan, while acknowledging that it has not been clinically proven to cure COVID-19. The company is currently testing 10 candidates for the coronavirus on animals that could lead to clinical trials.

 

Johnson & Johnson's Dutch vaccine unit, Janssen Vaccines & Prevention, intends to utilize its proprietary technology that can greatly ramp up production, used in the development of the Ebola vaccine, which is currently deployed in the Democratic Republic of the Congo and Rwanda, and for Zika, RSV and HIV vaccine candidates.

 

In a multi-pronged approach, the U.S. parent is also pursuing research to find effective treatments against COVID-19, which has claimed more than 11,000 lives.

https://asia.nikkei.com/Editor-s-Picks/Interview/Johnson-Johnson-tests-10-variants-of-coronavirus-vaccine